• Explore /
  • Poster
  • / Impact of gender on multikinase inhibitors (MKIs) toxicity in patients (pts) with advanced pancreatic and gastrointestinal neuroendocrine tumors (NETs): A pooled analysis of two phase II trials with pazopanib and lenvatinib.

Impact of gender on multikinase inhibitors (MKIs) toxicity in patients (pts) with advanced pancreatic and gastrointestinal neuroendocrine tumors (NETs): A pooled analysis of two phase II trials with pazopanib and lenvatinib.

Abstract Poster

Authors

null

Jorge Hernando-Cubero

Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Bracelona, Spain

Jorge Hernando-Cubero , Enrique Grande , Daniel E. Castellano , Toni Ibrahim , Nicola Fazio , Carlos Lopez , Alex Teule , Juan W. Valle , Rocio Garcia-Carbonero , Marc Diez , Daniel Acosta , Maria Roca , Jaume Capdevila

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Neuroendocrine/Carcinoid

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4109)

DOI

10.1200/JCO.2019.37.15_suppl.4109

Abstract #

4109

Poster Bd #

214

Abstract Disclosures

Similar Posters

Poster

2015 ASCO Annual Meeting

A phase II study of axitinib in advanced carcinoid tumors: Preliminary results.

A phase II study of axitinib in advanced carcinoid tumors: Preliminary results.

First Author: Mauro Cives

First Author: Steven O'Day

First Author: Martin Schlumberger

First Author: Wen Wee Ma